Comment on ‘exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy’

• Jiaqing Wang,
• Yi Qin

Affiliations

Jiaqing Wang

Department of Clinical Laboratory, Shaoxing Central Hospital, The Central Affiliated Hospital, Shaoxing University, Shaoxing, Zhejiang, China

Yi Qin

Department of Clinical Laboratory, People’s Hospital of Anji, Huzhou, Zhejiang, China